TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
121 hedge funds and large institutions have $262M invested in Tvardi Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
121
Holders Change
-6
Holders Change %
-4.72%
% of All Funds
3.02%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
20
Increased
33
Reduced
40
Closed
24
Calls
$7.1M
Puts
$11.4M
Net Calls
-$4.33M
Net Calls Change
+$11.3M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$5.02M |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$2.6M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.8M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$1.73M |
| 5 |
BlackRock
New York
|
+$1.52M |
Top Sellers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.82M |
| 2 |
Morgan Stanley
New York
|
-$4.76M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$3.27M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.54M |
| 5 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$2.19M |
